GSK brings weight loss capsule back one year after recall

Drug maker GlaxoSmithKline (NYSE: GSK) announced the return of its over-the-counter weight loss aid alli, just less than one year after it voluntarily removed the product from shelves fearing that some of the packages had been tampered. Glaxo says it improved the packaging. Last year, the company determined that some packages did not contain authentic alli capsules and recalled the product in the United States and Puerto Rico. GSK does not specifically break out sales figures for alli. The produce…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news